Antibiotice Ia (ATB) — Defensive Interval Ratio

Latest as of December 2025: 494 days

Antibiotice Ia (ATB) has a Defensive Interval Ratio of 494 days as of December 2025. Defensive assets of RON339.09 Million (cash RON-, short-term investments RON-, receivables RON339.09 Million) cover 494 days of daily cash needs of RON685.92K/day. Check tangible equity quality of Antibiotice Ia to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

494 days
Days of operational coverage

Defensive Assets

RON339.09 Million
Cash + ST Investments + Receivables

Daily Cash Need

RON685.92K
Current Liabilities ÷ 365

Current Liabilities

RON250.36 Million
RON

Antibiotice Ia Defensive Interval Ratio (2020–2025)

This chart shows how Antibiotice Ia's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 494 days, meaning defensive assets of RON339.09 Million can fund 494 days of operations without new revenue. Also explore ATB year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Antibiotice Ia (2020–2025)

The table below presents the year-by-year Defensive Interval Ratio for Antibiotice Ia from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Antibiotice Ia stock valuation.

Year DIR (days) Defensive Assets (RON) Daily Cash Need Cash ST Investments Change (days)
2025 494 days RON339.09 Million RON685.92K/day RON- RON- ▲ +10 days
2024 484 days RON311.94 Million RON643.99K/day RON- RON- ▲ +7 days
2023 478 days RON249.29 Million RON521.84K/day RON- RON- ▼ -73 days
2022 550 days RON204.03 Million RON370.80K/day RON- RON- ▲ +56 days
2021 494 days RON269.76 Million RON545.58K/day RON- RON- ▲ +0 days
2020 494 days RON252.90 Million RON511.50K/day RON- RON-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)